Additionally, we find that malonate is released by the endothelium when IGF-1R levels are reduced, functioning as a WAT modulator with therapeutic potential in the context of obesity and related metabolic complications. Here, IGF1R is linked to obesity due to melanocortin 4 receptor deficiency.